BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 1347465)

  • 1. Pathogenesis of peritoneal fibrosing syndromes (sclerosing peritonitis) in peritoneal dialysis.
    Dobbie JW
    Perit Dial Int; 1992; 12(1):14-27. PubMed ID: 1347465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between peritoneal mesothelial cell cytology and peritoneal histopathology with respect to prognosis in patients on continuous ambulatory peritoneal dialysis.
    Izumotani T; Ishimura E; Yamamoto T; Otoshi T; Okuno S; Inaba M; Kim M; Nishizawa Y
    Nephron; 2001 Sep; 89(1):43-9. PubMed ID: 11528231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The spectrum of peritoneal fibrosing syndromes in peritoneal dialysis.
    Mactier RA
    Adv Perit Dial; 2000; 16():223-8. PubMed ID: 11045299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sclerosing peritonitis with mural bowel fibrosis in a patient on long-term CAPD.
    Hauglustaine D; van Meerbeek J; Monballyu J; Goddeeris P; Lauwerijns J; Michielsen P
    Clin Nephrol; 1984 Sep; 22(3):158-62. PubMed ID: 6488597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors increasing severity of peritonitis in long-term peritoneal dialysis patients.
    Park MS
    Adv Ren Replace Ther; 1998 Jul; 5(3):185-93. PubMed ID: 9686629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced glycation end-products and peritoneal sclerosis.
    Nakamura S; Niwa T
    Semin Nephrol; 2004 Sep; 24(5):502-5. PubMed ID: 15490420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Encapsulating peritonitis during continuous ambulatory peritoneal dialysis. A physiopathologic hypothesis].
    Verger C; Celicout B; Larpent L; Goupil A
    Presse Med; 1986 Sep; 15(28):1311-4. PubMed ID: 2950390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term effects of peritoneal dialysis on peritoneal morphology.
    Dobbie JW; Anderson JD; Hind C
    Perit Dial Int; 1994; 14 Suppl 3():S16-20. PubMed ID: 7948267
    [No Abstract]   [Full Text] [Related]  

  • 9. Sclerosing encapsulating peritonitis.
    Novello AC; Port FK
    Int J Artif Organs; 1986 Nov; 9(6):393-6. PubMed ID: 2880809
    [No Abstract]   [Full Text] [Related]  

  • 10. Persistent transforming growth factor-beta 1 expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence.
    Lin CY; Chen WP; Yang LY; Chen A; Huang TP
    Am J Nephrol; 1998; 18(6):513-9. PubMed ID: 9845827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent transforming growth factor beta 1 expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence.
    Lin CY; Chen WP; Fu LW; Yang LY; Huang TP
    Adv Perit Dial; 1997; 13():64-71. PubMed ID: 9360653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sclerosing obstructive peritonitis after CAPD.
    Oreopoulos DG; Khanna R; Wu G
    Lancet; 1983 Aug; 2(8346):409. PubMed ID: 6135907
    [No Abstract]   [Full Text] [Related]  

  • 13. Sclerosing peritonitis.
    Bowers VD; Ackermann JR; Richardson W; Carey LC
    Clin Transplant; 1994 Aug; 8(4):369-72. PubMed ID: 7949541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sclerosing peritonitis in continuous ambulatory peritoneal dialysis patients: one center's experience and review of the literature.
    Afthentopoulos IE; Passadakis P; Oreopoulos DG; Bargman J
    Adv Ren Replace Ther; 1998 Jul; 5(3):157-67. PubMed ID: 9686626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphology of the peritoneum in CAPD.
    Dobbie JW
    Blood Purif; 1989; 7(2-3):74-85. PubMed ID: 2663038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Successful Treatment of Encapsulating Peritoneal Sclerosis in an Adolescent Boy on Long-term Peritoneal Dialysis: A Case Report.
    Zvizdic Z; Summers A; Moinuddin Z; Van Dellen D; Pasic-Sefic I; Skenderi F; Vranic S; Augustine T
    Prague Med Rep; 2020; 121(4):254-261. PubMed ID: 33270013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sclerosing encapsulating peritonitis as a complication of long-term continuous ambulatory peritoneal dialysis in Korea.
    Lee HY; Kim BS; Choi HY; Park HC; Kang SW; Choi KH; Ha SK; Han DS
    Nephrology (Carlton); 2003 Oct; 8 Suppl():S33-9. PubMed ID: 15012689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sclerosing encapsulating peritonitis secondary to CAPD: the effect of fibrotic debridement on further dialysis.
    Klimopoulos S; Katsoulis IE; Margellos V; Nikolopoulou N
    J R Coll Surg Edinb; 2002 Apr; 47(2):485-90. PubMed ID: 12018692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sclerosing obstructive peritonitis after continuous ambulatory peritoneal dialysis.
    Bradley JA; McWhinnie DL; Hamilton DN; Starnes F; Macpherson SG; Seywright M; Briggs JD; Junor BJ
    Lancet; 1983 Jul; 2(8341):113-4. PubMed ID: 6134956
    [No Abstract]   [Full Text] [Related]  

  • 20. Coagulation- and fibrinolysis-related antigens in plasma and dialysate of CAPD patients.
    Goedde M; Sitter T; Schiffl H; Bechtel U; Schramm W; Spannagl M
    Perit Dial Int; 1997; 17(2):162-6. PubMed ID: 9159837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.